Where does Development Center for Biotechnology rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Development Center for Biotechnology ranks #8,779 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Development Center for Biotechnology hold?

Development Center for Biotechnology holds 36 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Development Center for Biotechnology's Innovation Score?

Development Center for Biotechnology has an Innovation Score of 36.5 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Development Center for Biotechnology focus on?

Development Center for Biotechnology's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 27 patents, ranking #737 of 6,058 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Development Center for Biotechnology's patent grant rate increasing or decreasing?

Development Center for Biotechnology's recent grant velocity is +13% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Development Center for Biotechnology's patents?

Development Center for Biotechnology's patents average 14.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Development Center for Biotechnology patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Development Center for Biotechnology

USPTO PatentsView assignee record - 36 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Development ranks #8,779 of 49,997 tracked US assignees by granted-patent volume, with 36 patents across 12 technology areas.

#8,779
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.5/100): 14.4
avg claims per patent: +13%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8779 · Foreign Corporation #8,779 · 36 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 36 grants
UPPER-Q #8,779/49,997
PHOTO-FINISH Daniel Measurement…
CPC-FOCUS A61P · 12 areas
INNOV-THIN 36.5/100
CLAIMS-RICH 14.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +13% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Daniel Measurement and Control, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Development’s 36.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.5 pts (34%) Velocity 3.1 pts (8%) Breadth 12.2 pts (33%) Claim depth 8.7 pts (24%)

Qualcomm Incorporated · highest

85
Allnex Austria · near

36
Development Center… · this assignee

36
Vatech · near

36
Wayne Fueling… · near

36
Parfums Christian Dior · near

36
3D Lighting… · lowest

7

What this shows Development's Innovation Score is 36.5/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Development?

Each dot is one of Development’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Development’s own 14.4 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Development vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Development's grants concentrate

Development Center for Biotechnology is a focused PatentsView assignee: 12 CPC subclasses with 75% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (9 grants) versus a trough of 1 in 2019. By volume, Development sits between Dedon GmbH and DuPont Industrial Biosciences USA, LLC.

Development's three-year grant acceleration

Development Center for Biotechnology shows 6 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Dedon

36
Doosan Machine To…

36
Duke Energy

36
Daniel Measuremen…

36
Diehl AKO Stiftun…

36
Drfirst com

36
Draeger Medical S…

36
Dupont Industrial…

36
Development Cente… ◀

36

What this shows Development holds 36 patents at rank #8,781, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Development

By rank, the assignees closest to #8,781 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Development's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Development, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Development ranks #737 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Allnex Austria GMBH 36 Wayne Fueling Systems Sweden AB 36 Vatech Co., Ltd. 36 Parfums Christian Dior 36

Development's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Development Center for Biotechnology patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	8.3%
2016	8	22.2%
2017	2	5.6%
2018	2	5.6%
2019	1	2.8%
2020	9	25.0%
2021	3	8.3%
2022	3	8.3%
2024	3	8.3%
2025partial year	2	5.6%

Which technologies does Development Center for Biotechnology patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 27

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 27

C07K - Peptides 17

C07D - Heterocyclic Compounds 10

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C07C - Acyclic OR Carbocyclic Compounds 1

B63B - Ships OR Other Waterborne VESSELS; Equipment FOR Shipping 1

B63H - Marine Propulsion OR Steering 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Development Center for Biotechnology's patent record in context - here's where to go next.

Development Center for Biotechnology's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 75% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #8,779 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Development Center for Biotechnology against Dedon GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.